Contribution of syndecan-4 genetic variants to hypertension, the TAMRISK study
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 815
Abstract
A human syndecan-4 genetic variant (rs1981429) has previously been associated with lean tissue mass and intra-abdominal fat, and SNP rs4599 with resting energy expenditure in healthy early pubertal children. These variations could thus cause overweight and hypothetically lead to hypertension. Their association with body mass index and blood pressure was therefore studied in a Finnish cohort of adults. The data was collected from the Tampere adult population cardiovascular risk study (TAMRISK). A total of 279 cases with hypertension and/or coronary artery disease (CAD), and 488 non-hypertensive healthy controls were selected from a Finnish periodic health examination 50-year-old cohort. Information was available also from their 45-year examination. DNA was extracted from buccal swabs and human syndecan-4 gene SNPs were analyzed using KASP genotyping. The SNP rs1981429 variant TT was significantly associated with hypertension, as compared to variants TG and GG at the age of 50 years (p=0.015). The variant TT was also associated with increased BMI at the ages of 45 and 50 years (p=0.008 and p=0.026, respectively). In addition, TT genotype associated with increased CAD prevalence (P=0.013). No significant associations between rs4599 variants and hypertension or BMI were found. In haplotype analysis the number of alleles T (rs1981429)/C (rs4599) was linearly associated with CAD prevalence; the highest prevalence (13%) was in haplotype TT/CC and lowest prevalence (1%) in haplotype GG/TT (p=0.01). Syndecan-4 polymorphisms were associated with essential hypertension, BMI, and CAD prevalence in the TAMRISK study.Keywords
This publication has 20 references indexed in Scilit:
- Syndecan-4: A component of the mechanosensory apparatus of cardiac fibroblastsJournal of Molecular and Cellular Cardiology, 2013
- Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan‐4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure‐overloaded heartThe FEBS Journal, 2013
- A Conserved Role for Syndecan Family Members in the Regulation of Whole-Body Energy MetabolismPLOS ONE, 2010
- Genome-wide association study of blood pressure and hypertensionNature Genetics, 2009
- Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDLJournal of Lipid Research, 2009
- Syndecans in wound healing, inflammation and vascular biologyThe International Journal of Biochemistry & Cell Biology, 2007
- Heritability of Daytime Ambulatory Blood Pressure in an Extended Twin DesignHypertension, 2005
- Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populationsEuropean Journal of Public Health, 2004
- Increased syndecan expression following myocardial infarction indicates a role in cardiac remodelingPhysiological Genomics, 2004
- Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan SulfateAnnual Review of Biochemistry, 2002